VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 86 filers reported holding VERA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $444,245 | +105.9% | 32,403 | +141.0% | 0.00% | – |
| Q2 2023 | $215,760 | +560.9% | 13,443 | +219.5% | 0.00% | – |
| Q1 2023 | $32,646 | +552.9% | 4,207 | +1721.2% | 0.00% | – |
| Q3 2022 | $5,000 | 0.0% | 231 | -32.7% | 0.00% | – |
| Q2 2022 | $5,000 | -92.8% | 343 | -88.4% | 0.00% | – |
| Q1 2022 | $69,000 | -54.6% | 2,955 | -48.1% | 0.00% | – |
| Q4 2021 | $152,000 | +15100.0% | 5,697 | +12021.3% | 0.00% | – |
| Q3 2021 | $1,000 | – | 47 | +67.9% | 0.00% | – |
| Q2 2021 | $0 | – | 28 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 5,450,000 | $74,719,500 | 8.73% |
| Kynam Capital Management, LP | 2,956,053 | $40,527,487 | 6.63% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 758,355 | $10,381,880 | 3.50% |
| Sofinnova Investments, Inc. | 3,467,156 | $47,534,709 | 3.00% |
| Altium Capital Management LP | 333,681 | $4,574,767 | 2.39% |
| Eversept Partners, LP | 1,478,489 | $20,270,084 | 1.72% |
| SECTORAL ASSET MANAGEMENT INC | 357,139 | $4,896,376 | 0.95% |
| Carlyle Group Inc. | 1,438,155 | $19,688,342 | 0.85% |
| Orbimed Advisors | 1,518,115 | $20,813,357 | 0.44% |
| Woodline Partners LP | 2,562,600 | $35,133,246 | 0.41% |